KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Cash from Financing Activities (2016 - 2025)

Nektar Therapeutics has reported Cash from Financing Activities over the past 16 years, most recently at $38.7 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $38.7 million for Q4 2025, up 46491.57% from a year ago — trailing twelve months through Dec 2025 was $180.6 million (up 328.71% YoY), and the annual figure for FY2025 was $180.6 million, up 328.71%.
  • Cash from Financing Activities for Q4 2025 was $38.7 million at Nektar Therapeutics, down from $141.7 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for NKTR hit a ceiling of $141.7 million in Q3 2025 and a floor of $7000.0 in Q1 2025.
  • Median Cash from Financing Activities over the past 5 years was $467000.0 (2022), compared with a mean of $15.3 million.
  • Peak annual rise in Cash from Financing Activities hit 1089723.08% in 2025, while the deepest fall reached 99.98% in 2025.
  • Nektar Therapeutics' Cash from Financing Activities stood at $2.6 million in 2021, then tumbled by 95.96% to $103000.0 in 2022, then crashed by 88.35% to $12000.0 in 2023, then surged by 591.67% to $83000.0 in 2024, then skyrocketed by 46491.57% to $38.7 million in 2025.
  • The last three reported values for Cash from Financing Activities were $38.7 million (Q4 2025), $141.7 million (Q3 2025), and $211000.0 (Q2 2025) per Business Quant data.